Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
Objectives: IgA nephropathy (IgAN) is thought to involve an autoimmune process wherein galactose-deficient IgA1 (Gd-IgA1), recognized as autoantigen by autoantibodies, forms pathogenic immune complexes. Mounting evidence has implicated abnormal activation of some protein-tyrosine kinases (PTKs) in I...
Saved in:
Main Authors: | Koshi Yamada (Author), Zhi qiang Huang (Author), Milan Raska (Author), Colin Reily (Author), Joshua C. Anderson (Author), Hitoshi Suzuki (Author), Krzysztof Kiryluk (Author), Ali G. Gharavi (Author), Bruce A. Julian (Author), Christopher D. Willey (Author), Jan Novak (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019) -
Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients
by: Petr Kosztyu, et al.
Published: (2018) -
Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy
by: Caiqiong Liu, et al.
Published: (2021) -
Sulodexide in IgA nephropathy
Published: (2013) -
Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
by: Junjun Zhang, et al.
Published: (2021)